TG Therapeutics Inc (NASDAQ:TGTX)

6.04
Delayed Data
As of Sep 20
 -0.36 / -5.63%
Today’s Change
3.32
Today|||52-Week Range
9.38
+47.32%
Year-to-Date
No recent news for TG Therapeutics Inc.

Today’s Trading

Previous close6.40
Today’s open6.40
Day’s range6.02 - 6.48
Volume4,257,307
Average volume (3 months)1,328,839
Market cap$613.1M
Data as of 3:59pm ET, 09/20/2019

Growth & Valuation

Earnings growth (last year)-20.36%
Earnings growth (this year)--
Earnings growth (next 5 years)--
Revenue growth (last year)-0.25%
P/E ratioNM
Price/Sales2,035.62
Price/Book22.58

Competitors

 Today’s
change
Today’s
% change
RVNCRevance Therapeutics...+0.31+2.20%
MGNXMacroGenics Inc-0.13-1.00%
SVASinovac Biotech Ltd0.000.00%
QTRXQuanterix Corp+0.44+1.85%
Data as of 4:00pm ET, 09/20/2019

Financials

Next reporting dateNovember 6, 2019
EPS forecast (this quarter)-$0.35
Annual revenue (last year)$152.0K
Annual profit (last year)-$173.5M
Net profit margin-114,132.89%

Profile

Sector
Health Technology
Industry
Biotechnology
Executive Chairman, President &
CEO
Michael Sean Weiss
Chief Financial Officer, Secretary &
Treasurer
Sean A. Power
Corporate headquarters
New York, New York

Forecasts